Bought
Maintained
Sold
Other funds holding STE
OAG
GIM
Aviva's STE Position: Q2 2026 in Review
Aviva increased its Steris (STE) stake by 9.1% in Q2 2026, buying an estimated $1.68M and bringing the position to 93,823 shares worth $19.8M. The position accounts for 0.03% of the portfolio, ranked #424.
Aviva first reported a position in STE in Q3 2019 and has held it in 28 quarters since. The position peaked at $28.6M in Q1 2023. 830 funds tracked by Wall St. Rank hold STE as of Q2 2026.
- Aviva held 93,823 shares of Steris worth $19.8M as of Q2 2026.
- Aviva bought 7,818 Steris shares in Q2 2026, an estimated $1.68M.
- Steris made up 0.03% of Aviva's portfolio in Q2 2026, its #424 holding.
- Aviva first reported a position in Steris in Q3 2019 and has held it in 28 quarters since.
- Aviva's Steris position peaked at $28.6M in Q1 2023.
- 830 funds tracked by Wall St. Rank held Steris as of Q2 2026.
Based on Aviva's 13F filing for Q2 2026, filed 13 Aug 2026.